Literature DB >> 9128220

Vernix caseosa: an unusual cause of post-cesarean section peritonitis.

A Mahmoud1, S Silapaswan, K Lin, D Penney.   

Abstract

Surgeons should be aware of a very unusual cause of post-cesarean section peritonitis. This rare form of peritonitis is caused by the spillage of vernix caseosa material into the peritoneal cavity. The exact mechanism of the development of peritonitis in these few cases is unknown. Clinically, vernix caseosa peritonitis should be considered in the post-cesarean section acute abdomen after excluding the more common causes of peritonitis such as appendicitis and perforated viscus. Intraoperatively, the presence of cheese-like yellow patches limited to the serosal layer of visceral organs is the most characteristic feature. Histopathological examination of these serosal patches reveal the desquamated anuclear squamous cells confirming the diagnosis. Postoperative treatment with antibiotics should be continued. The addition of steroids (only after confirming the diagnosis pathologically) has a significant effect on improving the clinical outcome.

Entities:  

Mesh:

Year:  1997        PMID: 9128220

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  4 in total

1.  Unraveling the mystery of vernix caseosa.

Authors:  Gurcharan Singh; G Archana
Journal:  Indian J Dermatol       Date:  2008       Impact factor: 1.494

2.  Vernix caseosa peritonitis after vaginal delivery.

Authors:  Shameema A Sadath; Fathiya I Abo Diba; Surendra Nayak; Iman Al Shamali; Michael F Diejomaoh
Journal:  Clin Med Insights Case Rep       Date:  2013-10-10

3.  Vernix caseosa peritonitis - no longer rare or innocent: a case series.

Authors:  Olivia A Stuart; Alastair R Morris; Rodney J Baber
Journal:  J Med Case Rep       Date:  2009-02-10

Review 4.  Delayed presentation of vernix caseosa peritonitis.

Authors:  A C Chambers; A V Patil; R Alves; J C Hopkins; J Armstrong; R N Lawrence
Journal:  Ann R Coll Surg Engl       Date:  2012-11       Impact factor: 1.891

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.